Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Criteo (CRTO) Research & Development (2016 - 2026)

Criteo has reported Research & Development over the past 15 years, most recently at $69.7 million for Q1 2026.

  • Quarterly results put Research & Development at $69.7 million for Q1 2026, up 14.71% from a year ago — trailing twelve months through Mar 2026 was $277.6 million (up 1.6% YoY), and the annual figure for FY2025 was $283.3 million, up 1.42%.
  • Research & Development reached $69.7 million in Q1 2026 per CRTO's latest filing, down from $79.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $85.3 million in Q3 2024 and bottomed at $34.0 million in Q1 2022.
  • Median Research & Development over the past 5 years was $63.6 million (2023), compared with a mean of $61.3 million.
  • Peak annual rise in Research & Development hit 86.88% in 2023, while the deepest fall reached 30.2% in 2023.
  • Over 5 years, Research & Development stood at $69.3 million in 2022, then tumbled by 30.2% to $48.4 million in 2023, then skyrocketed by 39.58% to $67.6 million in 2024, then rose by 17.84% to $79.6 million in 2025, then fell by 12.47% to $69.7 million in 2026.
  • Business Quant data shows Research & Development for CRTO at $69.7 million in Q1 2026, $79.6 million in Q2 2025, and $60.7 million in Q1 2025.